FOXP3 and cancer: Our research results indicate that in EC, an elevated level of FOXP3 expression predicts a relatively poorer prognosis for patients, consistent with the conclusions of Wu et al. [58], suggesting that blocking FOXP3 expression in cancer cells may provide a new treatment strategy for EC.